Related Experiment Video
Updated: Sep 8, 2025

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Periocular Pigmented Basal Cell Carcinomas: Clinicopathologic Features and Mutational Profile
Fadi Hassanin1,2, Hailah Al Hussain1, Azza Maktabi1
1King Khaled Eye Specialty Hospital, Riyadh, Saudi Arabia.
Pigmented basal cell carcinoma (PBCC) of the eye region shares clinical traits with other BCCs. Genetic analysis revealed common mutations in PTCH1, TERT, and SMO, with novel drivers identified for potential targeted therapies.
Area of Science:
- Oncology
- Dermatology
- Genetics
Background:
- Pigmented basal cell carcinoma (PBCC) is an uncommon variant of basal cell carcinoma (BCC) affecting the periocular region.
- Limited literature exists on the specific clinicopathological profile and genetic landscape of periocular PBCC.
Purpose of the Study:
- To investigate the clinicopathological features of periocular PBCC.
- To identify and analyze somatic mutations within periocular PBCC.
- To compare these findings with non-PBCC of the periocular region and other BCC locations.
Main Methods:
- Clinicopathological data from 31 patients with periocular PBCC were collected.
- Next-generation sequencing panel analysis was performed on excised tumor samples.
- Data were compared with existing literature on periocular non-PBCC.
Main Results:
- PBCC was more prevalent in females and commonly presented as a solitary mass on the lower eyelid.
- Nodular or mixed subtypes were most frequent, with a low recurrence rate (3.5%).
- Somatic mutations were detected in 25/31 tumors, with common variants in PTCH1, TERT, and SMO. Novel drivers like POLE, FANCD2, and CREBBP were identified. SMO and TERT mutations showed associations with specific demographics and subtypes.
Conclusions:
- Periocular PBCC exhibits similar clinicopathological features and tumor behavior to periocular non-PBCC.
- The somatic mutation profile of PBCC aligns with nonperiocular cutaneous BCC, including the discovery of novel drivers.
- Identified actionable mutations offer potential targets for molecular therapy in PBCC.
More Related Videos
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
06:39Differentiation, Maintenance, and Analysis of Human Retinal Pigment Epithelium Cells: A Disease-in-a-dish Model for BEST1 Mutations
Published on: August 24, 2018
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...